{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:26:50Z","timestamp":1791570410416,"version":"4.3.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00277-019-03813-9","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T16:02:10Z","timestamp":1571846530000},"page":"2653-2660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Non-invasive urinary biomarkers of renal function in sickle cell disease: an overview"],"prefix":"10.1007","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7413-9158","authenticated-orcid":false,"given":"Mar\u00edlia Rocha","family":"Laurentino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio Luiz Arruda","family":"Parente Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia Leal Chagas","family":"Parente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldo Bezerra","family":"da Silva J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth De Francesco","family":"Daher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rom\u00e9lia Pinheiro Gon\u00e7alves","family":"Lemes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,23]]},"reference":[{"issue":"10053","key":"3813_CR1","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0140-6736(16)31743-3","volume":"388","author":"KS Reddy","year":"2016","unstructured":"Reddy KS (2016) Global Burden of Disease Study 2015 provides GPS for global health 2030. Lancet 388(10053):1448\u20131449","journal-title":"Lancet"},{"issue":"7","key":"3813_CR2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ajh.22045","volume":"86","author":"N Sundaram","year":"2011","unstructured":"Sundaram N, Bennett M, Wilhelm J, Kim MO, Atweh G, Devarajan P, Malik P (2011) Biomarkers for early detection of sickle nephropathy. Am J Hematol 86(7):559\u2013566","journal-title":"Am J Hematol"},{"issue":"10","key":"3813_CR3","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s00467-014-2821-8","volume":"29","author":"D Hamideh","year":"2014","unstructured":"Hamideh D, Raj V, Harrington T, Li H, Margolles E, Amole F, Garcia-Buitrago M, Ruiz P, Zilleruelo G, Alvarez O (2014) Albuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia. Pediatr Nephrol 29(10):1997\u20132003","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"3813_CR4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5935\/0101-2800.20130036","volume":"35","author":"LA Peres","year":"2013","unstructured":"Peres LA, Cunha J\u00fanior AD, Sch\u00e4fer AJ, Silva AL, Gaspar AD, Scarpari DF, Alves JB, Girelli Neto R, Oliveira TF (2013) Biomarkers of acute kidney injury. J Bras Nefrol 35(3):229\u2013236","journal-title":"J Bras Nefrol"},{"key":"3813_CR5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.pharmtox.48.113006.094615","volume":"48","author":"VS Vaidya","year":"2008","unstructured":"Vaidya VS, Ferguson MA, Bonventre JV (2008) Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 48:463\u2013493","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"3813_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bcmd.2014.11.019","volume":"54","author":"TE Santos","year":"2015","unstructured":"Santos TE, Gon\u00e7alves RP, Barbosa MC et al (2015) Monocyte chemoatractant protein-1: a potential biomarker of renal lesion and its relation with oxidative status in sickle cell disease. Blood Cells Mol Dis 54(3):297\u2013301","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"3813_CR7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4103\/2229-5151.141420","volume":"4","author":"S Sanjeevani","year":"2014","unstructured":"Sanjeevani S, Pruthi S, Kalra S, Goel A, Kalra OP (2014) Role of neutrophil gelatinase-associated lipocalin for early detection of acute kidney injury. Int J Crit Illn Inj Sci 4(3):223\u2013228","journal-title":"Int J Crit Illn Inj Sci"},{"issue":"10","key":"3813_CR8","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1097\/01.ASN.0000088027.54400.C6","volume":"14","author":"J Mishra","year":"2003","unstructured":"Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14(10):2534\u20132543","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"3813_CR9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11255-009-9608-z","volume":"42","author":"SS Soni","year":"2010","unstructured":"Soni SS, Cruz D, Bobek I, Chionh CY, Nalesso F, Lentini P, de Cal M, Corradi V, Virzi G, Ronco C (2010) NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol 42(1):141\u2013150","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"3813_CR10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1440-1797.2010.01317.x","volume":"15","author":"P Devarajan","year":"2010","unstructured":"Devarajan P (2010) Review: Neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology (Carlton) 15(4):419\u2013428","journal-title":"Nephrology (Carlton)"},{"issue":"5","key":"3813_CR11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2141.2010.08419.x","volume":"151","author":"GR Serjeant","year":"2010","unstructured":"Serjeant GR (2010) One hundred years of sickle cell disease. Br J Haematol 151(5):425\u2013429","journal-title":"Br J Haematol"},{"key":"3813_CR12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","volume":"14","author":"P Sundd","year":"2019","unstructured":"Sundd P, Gladwin MT, Novelli EM (2019) Pathophysiology of sickle cell disease. Annu Rev Pathol 14:263\u2013292","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"3813_CR13","first-page":"207","volume":"29","author":"MA Zago","year":"2007","unstructured":"Zago MA, Pinto ACS (2007) Fisiopatologia das doen\u00e7as falciformes: da muta\u00e7\u00e3o gen\u00e9tica \u00e0 insufici\u00eancia de m\u00faltiplos \u00f3rg\u00e3os. Rev. Bras Hematol. Hemoter. Set 29(3):207\u2013214","journal-title":"Set"},{"issue":"4","key":"3813_CR14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000350283","volume":"22","author":"AD Adekile","year":"2013","unstructured":"Adekile AD (2013) What\u2019s new in the pathophysiology of sickle cell disease? Med Princ Pract 22(4):311\u2013312","journal-title":"Med Princ Pract"},{"issue":"1","key":"3813_CR15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","volume":"21","author":"GJ Kato","year":"2007","unstructured":"Kato GJ, Gladwin MT, Steinberg MH (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 21(1):37\u201347","journal-title":"Blood Rev"},{"issue":"9","key":"3813_CR16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","volume":"84","author":"GJ Kato","year":"2009","unstructured":"Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT (2009) Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol 84(9):618\u2013625","journal-title":"Am J Hematol"},{"issue":"4","key":"3813_CR17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2141.2011.08961.x","volume":"156","author":"DC Rees","year":"2012","unstructured":"Rees DC, Gibson JS (2012) Biomarkers in sickle cell disease. Br J Haematol 156(4):433\u2013445","journal-title":"Br J Haematol"},{"issue":"1","key":"3813_CR18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.sjbs.2014.09.005","volume":"22","author":"GA Damanhouri","year":"2015","unstructured":"Damanhouri GA, Jarullah J, Marouf S, Hindawi SI, Mushtaq G, Kamal MA (2015) Clinical biomarkers in sickle cell disease. Saudi J Biol Sci 22(1):24\u201331","journal-title":"Saudi J Biol Sci"},{"issue":"3","key":"3813_CR19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bjhh.2015.01.008","volume":"37","author":"JA Moreira","year":"2015","unstructured":"Moreira JA, Laurentino MR, Machado RP, Barbosa MC, Gon\u00e7alves RP, Mota Ade M, Rocha LB, Martins AM, de Lima Arruda AB, de Souza IP, Gon\u00e7alves RP (2015) Pattern of hemolysis parameters and association with fetal hemoglobin in sickle cell anemia patients in steady state. Rev Bras Hematol Hemoter 37(3):167\u2013171","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"2","key":"3813_CR20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10739680490278592","volume":"11","author":"KA Nath","year":"2004","unstructured":"Nath KA, Katusic ZS, Gladwin MT (2004) The perfusion paradox and vascular instability in sickle cell disease. Microcirculation 11(2):179\u2013193","journal-title":"Microcirculation"},{"issue":"2","key":"3813_CR21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/CH-121661","volume":"58","author":"Y Lamarre","year":"2014","unstructured":"Lamarre Y, Hardy-Dessources MD, Romana M, Lalanne-Mistrih ML, Waltz X, Petras M, Doumdo L, Blanchet-Deverly A, Martino J, Tressi\u00e8res B, Maillard F, Tarer V, Etienne-Julan M, Connes P (2014) Relationships between systemic vascular resistance, blood rheology and nitric oxide in children with sickle cell anemia or sickle cell-hemoglobin C disease. Clin Hemorheol Microcirc 58(2):307\u2013316","journal-title":"Clin Hemorheol Microcirc"},{"key":"3813_CR22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1100\/tsw.2009.10","volume":"9","author":"MH Steinberg","year":"2009","unstructured":"Steinberg MH (2009) Genetic etiologies for phenotypic diversity in sickle cell anemia. Sci World J 9:46\u201367","journal-title":"Sci World J"},{"issue":"5989","key":"3813_CR23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.1194035","volume":"329","author":"SH Orkin","year":"2010","unstructured":"Orkin SH, Higgs DR (2010) Sickle cell disease at 100 years. Science. 329(5989):291\u2013292","journal-title":"Science."},{"issue":"1","key":"3813_CR24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MD.0b013e3181ca59b6","volume":"89","author":"G Maigne","year":"2010","unstructured":"Maigne G, Ferlicot S, Galacteros F, Belenfant X, Ulinski T, Niaudet P, Ronco P, Godeau B, Durrbach A, Sahali S, Lang P, Lambotte O, Audard V (2010) Glomerular lesions in patients with sickle cell disease. Medicine (Baltimore) 89(1):18\u201327","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"3813_CR25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/bjh.14842","volume":"179","author":"R Kormann","year":"2017","unstructured":"Kormann R, Jannot AS, Narjoz C, Ribeil JA, Manceau S, Delville M, Joste V, Pri\u00e9 D, Pouchot J, Thervet E, Courbebaisse M, Arlet JB (2017) Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target. Br J Haematol 179(2):323\u2013335","journal-title":"Br J Haematol"},{"issue":"6","key":"3813_CR26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217042","volume":"14","author":"JL Bundy","year":"2019","unstructured":"Bundy JL, Anderson BR, Francescatto L, Garrett ME, Soldano KL, Telen MJ, Davis EE, Ashley-Koch AE (2019) RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes. PLoS One 14(6):e0217042","journal-title":"PLoS One"},{"issue":"5","key":"3813_CR27","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2215\/CJN.08511109","volume":"5","author":"JP Haymann","year":"2010","unstructured":"Haymann JP, Stankovic K, Levy P, Avellino V, Tharaux PL, Letavernier E, Grateau G, Baud L, Girot R, Lionnet F (2010) Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clin J Am Soc Nephrol 5(5):756\u2013761","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"3813_CR28","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00467-010-1736-2","volume":"26","author":"AM Becker","year":"2011","unstructured":"Becker AM (2011) Sickle cell nephropathy: challenging the conventional wisdom. Pediatr Nephrol 26(12):2099\u20132109","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"3813_CR29","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00277-011-1327-8","volume":"90","author":"GB Da Silva","year":"2011","unstructured":"Da Silva GB, Lib\u00f3rio AB, Daher EF (2011) New insights on pathophysiology, clinical manifestations, diagnosis, and treatment of sickle cell nephropathy. Ann Hematol 90(12):1371\u20131379","journal-title":"Ann Hematol"},{"issue":"3","key":"3813_CR30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrneph.2015.8","volume":"11","author":"KA Nath","year":"2015","unstructured":"Nath KA, Hebbel RP (2015) Sickle cell disease: renal manifestations and mechanisms. Nat Rev Nephrol 11(3):161\u2013171","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"3813_CR31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/blood-2016-09-738104","volume":"129","author":"I Aban","year":"2017","unstructured":"Aban I, Baddam S, Hilliard LM, Howard TH, Feig DI, Lebensburger JD (2017) Severe anemia early in life as a risk factor for sickle-cell kidney disease. Blood. 129(3):385\u2013387","journal-title":"Blood."},{"issue":"6","key":"3813_CR32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjmed.2008.12.020","volume":"122","author":"G Tsaras","year":"2009","unstructured":"Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y (2009) Complications associated with sickle cell trait: a brief narrative review. Am J Med 122(6):507\u2013512","journal-title":"Am J Med"},{"issue":"2","key":"3813_CR33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/pbc.22189","volume":"54","author":"ST Miller","year":"2010","unstructured":"Miller ST, Wang WC, Iyer R, Rana S, Lane P, Ware RE, Li D, Rees RC, BABY-HUG Investigators (2010) Urine concentrating ability in infants with sickle cell disease: baseline data from the phase III trial of hydroxyurea (BABY HUG). Pediatr Blood Cancer 54(2):265\u2013268","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"3813_CR34","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s11255-018-1803-3","volume":"50","author":"E Hariri","year":"2018","unstructured":"Hariri E, Mansour A, El Alam A et al (2018) Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment. Int Urol Nephrol 50(6):1075\u20131083","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"3813_CR35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12882-018-0939-9","volume":"19","author":"A Le Joncour","year":"2018","unstructured":"Le Joncour A, Mesnard L, Hertig A, Robert T et al (2018) Red urine, updated for the nephrologist: a case report. BMC Nephrol 19(1):133","journal-title":"BMC Nephrol"},{"issue":"2","key":"3813_CR36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9343(96)00407-X","volume":"102","author":"CH Pegelow","year":"1997","unstructured":"Pegelow CH, Colangelo L, Steinberg M, Wright EC, Smith J, Phillips G, Vichinsky E (1997) Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med 102(2):171\u2013177","journal-title":"Am J Med"},{"issue":"2","key":"3813_CR37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10739680490278592","volume":"11","author":"KA Nath","year":"2004","unstructured":"Nath KA, Katusic ZS, Gladwin MT (2004) The perfusion paradox and vascular instability in sickle cell disease. Microcirculation. 11(2):179\u2013193","journal-title":"Microcirculation."},{"issue":"10037","key":"3813_CR38","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/S0140-6736(16)00647-4","volume":"387","author":"MT Gladwin","year":"2016","unstructured":"Gladwin MT (2016) Cardiovascular complications and risk of death in sickle-cell disease. Lancet. 387(10037):2565\u20132574","journal-title":"Lancet."},{"issue":"12","key":"3813_CR39","doi-asserted-by":"crossref","first-page":"e114309","DOI":"10.1371\/journal.pone.0114309","volume":"9","author":"EM Novelli","year":"2014","unstructured":"Novelli EM, Hildesheim M, Rosano C, Vanderpool R, Simon M, Kato GJ, Gladwin MT (2014) Elevated pulse pressure is associated with hemolysis, proteinuria and chronic kidney disease in sickle cell disease. PLoS One 9(12):e114309","journal-title":"PLoS One"},{"issue":"1","key":"3813_CR40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajh.21016","volume":"83","author":"VR Gordeuk","year":"2008","unstructured":"Gordeuk VR, Sachdev V, Taylor JG, Gladwin MT, Kato G, Castro OL (2008) Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency. Am J Hematol 83(1):15\u201318","journal-title":"Am J Hematol"},{"issue":"1","key":"3813_CR41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190347","volume":"13","author":"A Benneh-Akwasi Kuma","year":"2018","unstructured":"Benneh-Akwasi Kuma A, Owusu-Ansah AT, Ampomah MA, Sey F, Olayemi E, Nouraie M, Ofori-Acquah SF (2018) Prevalence of relative systemic hypertension in adults with sickle cell disease in Ghana. PLoS One 13(1):e0190347","journal-title":"PLoS One"},{"issue":"4","key":"3813_CR42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ajh.25390","volume":"94","author":"JD Lebensburger","year":"2019","unstructured":"Lebensburger JD, Aban I, Pernell B, Kasztan M, Feig DI, Hilliard LM, Askenazi DJ (2019) Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy. Am J Hematol 94(4):417\u2013423","journal-title":"Am J Hematol"},{"issue":"6","key":"3813_CR43","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1681\/ASN.2014111126","volume":"27","author":"P Bartolucci","year":"2016","unstructured":"Bartolucci P, Habibi A, Stehl\u00e9 T, di Liberto G, Rakotoson MG, Gellen-Dautremer J, Loric S, Moutereau S, Sahali D, Wagner-Ballon O, Remy P, Lang P, Grimbert P, Audureau E, Godeau B, Galacteros F, Audard V (2016) Six months of hydroxyurea reduces albuminuria in patients with sickle cell disease. J Am Soc Nephrol 27(6):1847\u20131853","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"3813_CR44","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7326\/0003-4819-115-8-614","volume":"115","author":"DR Powars","year":"1991","unstructured":"Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, Johnson C (1991) Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med 115(8):614\u2013620","journal-title":"Ann Intern Med"},{"issue":"5","key":"3813_CR45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/03630269.2016.1224766","volume":"40","author":"Y Sl","year":"2016","unstructured":"Sl Y, Paul Y, Oneal P, Nouraie M (2016) Renal failure in sickle cell disease: prevalence, predictors of disease, mortality and effect on length of hospital stay. Hemoglobin 40(5):295\u2013299","journal-title":"Hemoglobin"},{"issue":"12","key":"3813_CR46","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.2215\/CJN.00740110","volume":"5","author":"JL Koyner","year":"2010","unstructured":"Koyner JL, Vaidya VS, Bennett MR, Ma Q, Worcester E, Akhter SA, Raman J, Jeevanandam V, O'Connor MF, Devarajan P, Bonventre JV, Murray PT (2010) Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 5(12):2154\u20132165 Epub 2010 Aug 26","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"3813_CR47","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/pbc.20169","volume":"44","author":"R Iannone","year":"2005","unstructured":"Iannone R, Ohene-Frempong K, Fuchs EJ, Casella JF, Chen AR (2005) Bone marrow transplantation for sickle cell anemia: progress and prospects. Pediatr Blood Cancer 44(5):436\u2013440","journal-title":"Pediatr Blood Cancer"},{"issue":"31-32","key":"3813_CR48","first-page":"532","volume":"108","author":"E Kohne","year":"2011","unstructured":"Kohne E (2011) Hemoglobinopathies: clinical manifestations, diagnosis, and treatment. Dtsch Arztebl Int 108(31-32):532\u2013540","journal-title":"Dtsch Arztebl Int"},{"key":"3813_CR49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-med-041817-125507","volume":"70","author":"SH Orkin","year":"2019","unstructured":"Orkin SH, Bauer DE (2019) Emerging genetic therapy for sickle cell disease. Annu Rev Med 70:257\u2013271","journal-title":"Annu Rev Med"},{"issue":"3","key":"3813_CR50","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.2002.03919.x","volume":"119","author":"M Nahavandi","year":"2002","unstructured":"Nahavandi M, Tavakkoli F, Wyche MQ, Perlin E, Winter WP, Castro O (2002) Nitric oxide and cyclic GMP levels in sickle cell patients receiving hydroxyurea. Br J Haematol 119(3):855\u2013857","journal-title":"Br J Haematol"},{"issue":"2","key":"3813_CR51","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12288-013-0261-4","volume":"30","author":"RK Agrawal","year":"2014","unstructured":"Agrawal RK, Patel RK, Shah V, Nainiwal L, Trivedi B (2014) Hydroxyurea in sickle cell disease: drug review. Indian J Hematol Blood Transfus 30(2):91\u201396","journal-title":"Indian J Hematol Blood Transfus"},{"key":"3813_CR52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.niox.2018.10.003","volume":"81","author":"E Nader","year":"2018","unstructured":"Nader E, Grau M, Fort R et al (2018) Hydroxyurea therapy modulates sickle cell anemia red blood cell physiology: impact on RBC deformability, oxidative stress, nitrite levels and nitric oxide synthase signalling pathway. Nitric Oxide 81:28\u201335","journal-title":"Nitric Oxide"},{"issue":"3","key":"3813_CR53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MPH.0b013e3180335081","volume":"29","author":"KT Mckie","year":"2007","unstructured":"Mckie KT, Hanevold CD, Hernandez C et al (2007) Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease. J Pediatr Hematol Oncol 29(3):140\u2013144","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"3813_CR54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ajh.23365","volume":"88","author":"B Aygun","year":"2013","unstructured":"Aygun B, Mortier NA, Smeltzer MP, Shulkin BL, Hankins JS, Ware RE (2013) Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia. Am J Hematol 88(2):116\u2013119","journal-title":"Am J Hematol"},{"issue":"6","key":"3813_CR55","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/ndt\/gft295","volume":"29","author":"LP Laurin","year":"2014","unstructured":"Laurin LP, Nachman PH, Desai PC et al (2014) Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease. Nephrol Dial Transplant 29(6):1211\u20131218","journal-title":"Nephrol Dial Transplant"},{"key":"3813_CR56","first-page":"CD012380","volume":"7","author":"NB Roy","year":"2017","unstructured":"Roy NB, Fortin PM, Bull KR et al (2017) Interventions for chronic kidney disease in people with sickle cell disease. Cochrane Database Syst Rev 7:CD012380","journal-title":"Cochrane Database Syst Rev"},{"key":"3813_CR57","first-page":"CD003146","volume":"1","author":"LJ Estcourt","year":"2017","unstructured":"Estcourt LJ, Fortin PM, Hopewell S et al (2017) Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. Cochrane Database Syst Rev 1:CD003146","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"3813_CR58","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","volume":"312","author":"BP Yawn","year":"2014","unstructured":"Yawn BP, Buchanan GR, Afenyi-Annan AN et al (2014) Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 312(10):1033\u20131048","journal-title":"JAMA."},{"issue":"2-3","key":"3813_CR59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3233\/CH-189006","volume":"68","author":"JA Detterich","year":"2018","unstructured":"Detterich JA (2018) Simple chronic transfusion therapy, a crucial therapeutic option for sickle cell disease, improves but does not normalize blood rheology: what should be our goals for transfusion therapy? Clin Hemorheol Microcirc 68(2-3):173\u2013186","journal-title":"Clin Hemorheol Microcirc"},{"issue":"10091","key":"3813_CR60","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","volume":"390","author":"RE Ware","year":"2017","unstructured":"Ware RE, de Montalembert M, Tshilolo L, Abboud MR (2017) Sickle cell disease. Lancet 390(10091):311\u2013323","journal-title":"Lancet"},{"issue":"1","key":"3813_CR61","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/bjh.13791","volume":"172","author":"JC Wood","year":"2016","unstructured":"Wood JC, Cohen AR, Pressel SL, Aygun B, Imran H, Luchtman-Jones L, Thompson AA, Fuh B, Schultz WH, Davis BR, Ware RE, TWiTCH Investigators (2016) Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial. Br J Haematol 172(1):122\u2013130","journal-title":"Br J Haematol"},{"issue":"2","key":"3813_CR62","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1681\/ASN.V132423","volume":"13","author":"J Gburek","year":"2002","unstructured":"Gburek J, Verroust PJ, Willnow TE, Fyfe JC, Nowacki W, Jacobsen C, Moestrup SK, Christensen EI (2002) Megalin and cubilin are endocytic receptors involved in renal clearance of hemoglobin. J Am Soc Nephrol 13(2):423\u2013430","journal-title":"J Am Soc Nephrol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03813-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03813-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03813-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T11:39:13Z","timestamp":1664710753000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03813-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,23]]},"references-count":62,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3813"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03813-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,23]]},"assertion":[{"value":"12 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}